Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.

Philips will halt sales of its bilevel positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) machines under a tentative agreement it reached with the U.S. Food and Drug ...

Though Philips has argued in court that its U.S. subsidiary should bear the sole responsibility of paying out damages related to its massive CPAP machine recall, instructions to continue selling ...

Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

In 2021, polyester-based polyurethane (PE-PUR) foam used in Philips Respironics ventilators, CPAP and BiPAP machines was found to degrade and cause serious health issues or death, leading to a mass ...

Millions of CPAP sleep apnea machines made by the medical device maker Philips and a subsidiary were found to have a dangerous problem, triggering consumer lawsuits and a massive recall in 2021. Now, ...

Almost two full years into its Class I recall of more than 5 million respiratory devices, Philips has wrapped up safety tests covering nearly all of the affected models—and is reiterating its previous ...